(Meredith) -- A pharmaceutical company is recalling birth control pills sold nationwide due to a packaging error that may cause people to take the incorrect doses, the U.S. Food and Drug Administration announced Monday.
Apotex Corp. issued the voluntary recall on four lots of Drospirenone and Ethinyl Estradiol Tablets, USP because they may contain defective blisters with incorrect tablet arrangements and/or missing tablets.
"As a result of this packaging error, where a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to the variation of the dosage consumed," the company said in a press release.
Apotex said no one has reported a surprise pregnancy or any sickness related to the recall, to date.
A detailed product description of the recalled tablets is listed below:
The FDA is advising patients to use a non-hormonal method of birth control, contact their health care providers for medical advice and return the impacted packages to their pharmacists.
Anyone with questions regarding this recall can contact Apotex at 1-800-706-5575 (8:30 a.m. – 5:00 p.m., EST Monday through Friday) or via email at UScustomerservice@Apotex.com .